Starpharma Announces Collaboration, License Deal with Genentech
Starpharma has signed a collaboration and license agreement with Genentech to apply its DEP dendrimer drug-delivery platform to Genentech...
Plus Therapeutics Gets Additional $1.9M Advance From CPRIT
Plus Therapeutics has received an additional $1.9 million advance from the Cancer Prevention and Research Institute of Texas, part...
Helio: A European CDMO Dedicated to In Vitro Diagnostics
Helio Diagnostics has launched as a Europe-based, end-to-end contract development and manufacturing partner focused exclusively on in vitro diagnostics....
Idorsia’s Quviviq Launches in China, Expands Globally
Simcere has launched Quviviq (daridorexant) in mainland China for adult insomnia, with a notable regulatory distinction: the drug enters...
NexoBrid Takes Spotlight at European Burns Association Congress
MediWound’s NexoBrid will take center stage at the European Burns Association Congress in Berlin this week, featured across 36...
Clearmind Medicine Secures $10M for Strategic Opportunities
Clearmind Medicine has arranged up to $10 million in convertible note financing with institutional investors, securing an initial $500,000...
NTA Implant Solidifies Leadership with MDR Certification
NTA Implant, the dental implant brand of Switzerland-based Pilatus Swiss Dental GmbH, has secured European Union Medical Device Regulation...
Bylvay (odévixibat) Approved in Japan for Rare Liver Disease
Japan’s Ministry of Health, Labour and Welfare has approved Bylvay (odevixibat) for pruritus associated with progressive familial intrahepatic cholestasis...
Kraig Biocraft’s Surging Spider Silk Manufacturing Growth
Kraig Biocraft Laboratories plans to acquire an additional silkworm rearing center to expand production of its recombinant spider silk,...
Regeneron’s Gift: New Hope Against Devastating Ebola Risk
Regeneron will donate up to 500 doses of Inmazeb, its FDA‑approved monoclonal antibody cocktail for infection caused by Orthoebolavirus...